nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylpropanolamine—Urinary hesitation—Propantheline—pancreatitis	0.0919	0.146	CcSEcCtD
Phenylpropanolamine—Urinary hesitation—Hyoscyamine—pancreatitis	0.047	0.0748	CcSEcCtD
Phenylpropanolamine—Pulmonary function test decreased—Hyoscyamine—pancreatitis	0.0256	0.0407	CcSEcCtD
Phenylpropanolamine—Respiratory depression—Hyoscyamine—pancreatitis	0.0256	0.0407	CcSEcCtD
Phenylpropanolamine—Drowsiness—Propantheline—pancreatitis	0.0211	0.0335	CcSEcCtD
Phenylpropanolamine—Blood pressure increased—Hyoscyamine—pancreatitis	0.0193	0.0307	CcSEcCtD
Phenylpropanolamine—Flushing—Propantheline—pancreatitis	0.0176	0.0279	CcSEcCtD
Phenylpropanolamine—Tension—Propantheline—pancreatitis	0.0162	0.0257	CcSEcCtD
Phenylpropanolamine—Nervousness—Propantheline—pancreatitis	0.016	0.0254	CcSEcCtD
Phenylpropanolamine—Vision blurred—Propantheline—pancreatitis	0.0155	0.0247	CcSEcCtD
Phenylpropanolamine—Psychotic disorder—Hyoscyamine—pancreatitis	0.0137	0.0217	CcSEcCtD
Phenylpropanolamine—Confusional state—Propantheline—pancreatitis	0.0136	0.0216	CcSEcCtD
Phenylpropanolamine—Irritability—Hyoscyamine—pancreatitis	0.0134	0.0212	CcSEcCtD
Phenylpropanolamine—Urinary retention—Hyoscyamine—pancreatitis	0.0133	0.0212	CcSEcCtD
Phenylpropanolamine—Ataxia—Hyoscyamine—pancreatitis	0.0132	0.0209	CcSEcCtD
Phenylpropanolamine—Tachycardia—Propantheline—pancreatitis	0.0131	0.0209	CcSEcCtD
Phenylpropanolamine—Insomnia—Propantheline—pancreatitis	0.0122	0.0193	CcSEcCtD
Phenylpropanolamine—Somnolence—Propantheline—pancreatitis	0.012	0.019	CcSEcCtD
Phenylpropanolamine—Constipation—Propantheline—pancreatitis	0.0115	0.0183	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Propantheline—pancreatitis	0.0111	0.0176	CcSEcCtD
Phenylpropanolamine—Drowsiness—Hyoscyamine—pancreatitis	0.0108	0.0172	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Propantheline—pancreatitis	0.00991	0.0157	CcSEcCtD
Phenylpropanolamine—Hallucination—Hyoscyamine—pancreatitis	0.00964	0.0153	CcSEcCtD
Phenylpropanolamine—Flushing—Hyoscyamine—pancreatitis	0.00899	0.0143	CcSEcCtD
Phenylpropanolamine—Dizziness—Propantheline—pancreatitis	0.00889	0.0141	CcSEcCtD
Phenylpropanolamine—Arrhythmia—Hyoscyamine—pancreatitis	0.00865	0.0138	CcSEcCtD
Phenylpropanolamine—Vomiting—Propantheline—pancreatitis	0.00855	0.0136	CcSEcCtD
Phenylpropanolamine—Rash—Propantheline—pancreatitis	0.00848	0.0135	CcSEcCtD
Phenylpropanolamine—Dermatitis—Propantheline—pancreatitis	0.00847	0.0135	CcSEcCtD
Phenylpropanolamine—Tension—Hyoscyamine—pancreatitis	0.00828	0.0132	CcSEcCtD
Phenylpropanolamine—Nervousness—Hyoscyamine—pancreatitis	0.00819	0.013	CcSEcCtD
Phenylpropanolamine—Nausea—Propantheline—pancreatitis	0.00799	0.0127	CcSEcCtD
Phenylpropanolamine—Vision blurred—Hyoscyamine—pancreatitis	0.00795	0.0126	CcSEcCtD
Phenylpropanolamine—Agitation—Hyoscyamine—pancreatitis	0.00775	0.0123	CcSEcCtD
Phenylpropanolamine—Benzyl alcohol—ALDH2—pancreatitis	0.0074	0.731	CrCbGaD
Phenylpropanolamine—Anxiety—Hyoscyamine—pancreatitis	0.00716	0.0114	CcSEcCtD
Phenylpropanolamine—Confusional state—Hyoscyamine—pancreatitis	0.00694	0.011	CcSEcCtD
Phenylpropanolamine—Tachycardia—Hyoscyamine—pancreatitis	0.00672	0.0107	CcSEcCtD
Phenylpropanolamine—Hypotension—Hyoscyamine—pancreatitis	0.00643	0.0102	CcSEcCtD
Phenylpropanolamine—Insomnia—Hyoscyamine—pancreatitis	0.00623	0.0099	CcSEcCtD
Phenylpropanolamine—Dyspnoea—Hyoscyamine—pancreatitis	0.00614	0.00975	CcSEcCtD
Phenylpropanolamine—Somnolence—Hyoscyamine—pancreatitis	0.00612	0.00973	CcSEcCtD
Phenylpropanolamine—Constipation—Hyoscyamine—pancreatitis	0.00589	0.00936	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Hyoscyamine—pancreatitis	0.00567	0.00902	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Hyoscyamine—pancreatitis	0.00507	0.00806	CcSEcCtD
Phenylpropanolamine—Dizziness—Hyoscyamine—pancreatitis	0.00455	0.00724	CcSEcCtD
Phenylpropanolamine—Vomiting—Hyoscyamine—pancreatitis	0.00438	0.00696	CcSEcCtD
Phenylpropanolamine—Rash—Hyoscyamine—pancreatitis	0.00434	0.0069	CcSEcCtD
Phenylpropanolamine—Dermatitis—Hyoscyamine—pancreatitis	0.00434	0.00689	CcSEcCtD
Phenylpropanolamine—Nausea—Hyoscyamine—pancreatitis	0.00409	0.0065	CcSEcCtD
Phenylpropanolamine—Pseudoephedrine—TNF—pancreatitis	0.00272	0.268	CrCbGaD
Phenylpropanolamine—ADRA2A—Metabolism—PLA2G1B—pancreatitis	0.00013	0.000362	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—BDKRB2—pancreatitis	0.00013	0.000361	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—FDX1—pancreatitis	0.00013	0.000361	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—FGB—pancreatitis	0.00013	0.000359	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—HTR2A—pancreatitis	0.000129	0.000359	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—CCL5—pancreatitis	0.000129	0.000358	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—FGA—pancreatitis	0.000128	0.000355	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR downstream signaling—HTR2A—pancreatitis	0.000128	0.000355	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—CNR1—pancreatitis	0.000128	0.000355	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—KNG1—pancreatitis	0.000128	0.000354	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—PPP3CA—pancreatitis	0.000126	0.00035	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—A2M—pancreatitis	0.000126	0.000349	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—FGA—pancreatitis	0.000125	0.000347	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR downstream signaling—HTR2A—pancreatitis	0.000125	0.000347	CbGpPWpGaD
Phenylpropanolamine—SLC6A3—Neuronal System—HRAS—pancreatitis	0.000124	0.000343	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—GCG—pancreatitis	0.000124	0.000343	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—FGG—pancreatitis	0.000122	0.000338	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—CASR—pancreatitis	0.000122	0.000338	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—SCT—pancreatitis	0.000122	0.000338	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—SST—pancreatitis	0.000121	0.000336	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—ADH4—pancreatitis	0.000121	0.000336	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—DUSP6—pancreatitis	0.00012	0.000333	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—CX3CL1—pancreatitis	0.00012	0.000331	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—PTHLH—pancreatitis	0.000119	0.00033	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—SMO—pancreatitis	0.000119	0.00033	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—KNG1—pancreatitis	0.000119	0.000329	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatitis	0.000118	0.000327	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—CCL5—pancreatitis	0.000118	0.000326	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—FGB—pancreatitis	0.000117	0.000323	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—PTHLH—pancreatitis	0.000117	0.000323	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—SMO—pancreatitis	0.000117	0.000323	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—CCK—pancreatitis	0.000116	0.000322	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—MTNR1B—pancreatitis	0.000116	0.000322	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—HTR2A—pancreatitis	0.000116	0.000322	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—ALDH2—pancreatitis	0.000115	0.000319	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—FGB—pancreatitis	0.000114	0.000316	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—BDKRB2—pancreatitis	0.000114	0.000316	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—PRSS1—pancreatitis	0.000114	0.000316	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—HTR2A—pancreatitis	0.000114	0.000315	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—PPP3CA—pancreatitis	0.000114	0.000315	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—TACR1—pancreatitis	0.000113	0.000314	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—A2M—pancreatitis	0.000113	0.000314	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—CNR2—pancreatitis	0.000113	0.000314	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—FGG—pancreatitis	0.000113	0.000314	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—SCT—pancreatitis	0.000113	0.000314	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—CASR—pancreatitis	0.000113	0.000314	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR ligand binding—CXCL8—pancreatitis	0.000113	0.000314	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—pancreatitis	0.000113	0.000313	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—CNR1—pancreatitis	0.000112	0.00031	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—CCKAR—pancreatitis	0.000112	0.000309	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—PPP3CA—pancreatitis	0.000111	0.000308	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—CX3CL1—pancreatitis	0.000111	0.000308	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Hemostasis—ALB—pancreatitis	0.000111	0.000308	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—CCL5—pancreatitis	0.000109	0.000303	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—SST—pancreatitis	0.000109	0.000302	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—CCK—pancreatitis	0.000108	0.0003	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—MTNR1B—pancreatitis	0.000108	0.0003	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—GCG—pancreatitis	0.000108	0.000299	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—DUSP6—pancreatitis	0.000108	0.000299	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—PRSS3—pancreatitis	0.000108	0.000299	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—PNLIP—pancreatitis	0.000108	0.000299	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—CCL5—pancreatitis	0.000107	0.000296	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—SST—pancreatitis	0.000107	0.000295	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—DUSP6—pancreatitis	0.000106	0.000293	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—A2M—pancreatitis	0.000105	0.000292	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—CNR2—pancreatitis	0.000105	0.000292	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—TACR1—pancreatitis	0.000105	0.000292	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR ligand binding—CXCL8—pancreatitis	0.000105	0.000292	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—FGA—pancreatitis	0.000104	0.000287	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—KNG1—pancreatitis	0.000104	0.000287	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—HTR2A—pancreatitis	0.000104	0.000287	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—CCKAR—pancreatitis	0.000104	0.000287	CbGpPWpGaD
Phenylpropanolamine—MAOA—Metabolism—LPL—pancreatitis	0.000103	0.000284	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—BDKRB2—pancreatitis	0.000102	0.000284	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—CCL2—pancreatitis	0.000101	0.00028	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—CNR1—pancreatitis	0.000101	0.000279	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—BDKRB2—pancreatitis	0.0001	0.000278	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—CCL5—pancreatitis	9.92e-05	0.000275	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—CNR1—pancreatitis	9.84e-05	0.000273	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—GCG—pancreatitis	9.71e-05	0.000269	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—XDH—pancreatitis	9.68e-05	0.000268	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—PTHLH—pancreatitis	9.64e-05	0.000267	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—SMO—pancreatitis	9.64e-05	0.000267	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—FGA—pancreatitis	9.63e-05	0.000267	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—HTR2A—pancreatitis	9.63e-05	0.000267	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—PDGFA—pancreatitis	9.53e-05	0.000264	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—GCG—pancreatitis	9.5e-05	0.000263	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—FGB—pancreatitis	9.43e-05	0.000261	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—HTR2A—pancreatitis	9.41e-05	0.000261	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—KNG1—pancreatitis	9.32e-05	0.000258	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—PPP3CA—pancreatitis	9.2e-05	0.000255	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—KNG1—pancreatitis	9.12e-05	0.000253	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—CCL2—pancreatitis	9.09e-05	0.000252	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—ADH1B—pancreatitis	9.03e-05	0.00025	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—SMO—pancreatitis	8.96e-05	0.000248	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—PTHLH—pancreatitis	8.96e-05	0.000248	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—CCL2—pancreatitis	8.89e-05	0.000246	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—SST—pancreatitis	8.82e-05	0.000244	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR downstream signaling—CXCL8—pancreatitis	8.8e-05	0.000244	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—FGB—pancreatitis	8.77e-05	0.000243	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—HTR2A—pancreatitis	8.75e-05	0.000242	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—DUSP6—pancreatitis	8.74e-05	0.000242	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—GCG—pancreatitis	8.73e-05	0.000242	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—CCL5—pancreatitis	8.67e-05	0.00024	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—PDGFA—pancreatitis	8.57e-05	0.000238	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—PPP3CA—pancreatitis	8.54e-05	0.000237	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism of lipids and lipoproteins—LPL—pancreatitis	8.49e-05	0.000235	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—LPL—pancreatitis	8.48e-05	0.000235	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—PDGFA—pancreatitis	8.38e-05	0.000232	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—BDKRB2—pancreatitis	8.29e-05	0.00023	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—SST—pancreatitis	8.19e-05	0.000227	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—CNR1—pancreatitis	8.14e-05	0.000226	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—DUSP6—pancreatitis	8.12e-05	0.000225	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—SPP1—pancreatitis	8.03e-05	0.000223	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—CXCL8—pancreatitis	7.99e-05	0.000222	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR downstream signaling—CXCL8—pancreatitis	7.91e-05	0.000219	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—GCG—pancreatitis	7.86e-05	0.000218	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—CCL5—pancreatitis	7.79e-05	0.000216	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR downstream signaling—CXCL8—pancreatitis	7.74e-05	0.000215	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—BDKRB2—pancreatitis	7.7e-05	0.000213	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—HTR2A—pancreatitis	7.64e-05	0.000212	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—CCL5—pancreatitis	7.62e-05	0.000211	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—LPL—pancreatitis	7.62e-05	0.000211	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—CNR1—pancreatitis	7.56e-05	0.00021	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Hemostasis—NRAS—pancreatitis	7.55e-05	0.000209	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—KNG1—pancreatitis	7.54e-05	0.000209	CbGpPWpGaD
Phenylpropanolamine—MAOA—Metabolism—PPARG—pancreatitis	7.49e-05	0.000208	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—LPL—pancreatitis	7.46e-05	0.000207	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—CCL2—pancreatitis	7.35e-05	0.000204	CbGpPWpGaD
Phenylpropanolamine—MAOA—Metabolism—INS—pancreatitis	7.34e-05	0.000204	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—GCG—pancreatitis	7.3e-05	0.000202	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—SPP1—pancreatitis	7.22e-05	0.0002	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—PLA2G1B—pancreatitis	7.2e-05	0.0002	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—CXCL8—pancreatitis	7.19e-05	0.000199	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—LEP—pancreatitis	7.11e-05	0.000197	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—SPP1—pancreatitis	7.06e-05	0.000196	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—CXCL8—pancreatitis	7.03e-05	0.000195	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Hemostasis—TGFB1—pancreatitis	7.02e-05	0.000195	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—KNG1—pancreatitis	7.01e-05	0.000194	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—A2M—pancreatitis	6.95e-05	0.000193	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—PDGFA—pancreatitis	6.94e-05	0.000192	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—HTR2A—pancreatitis	6.87e-05	0.00019	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—LPL—pancreatitis	6.85e-05	0.00019	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—CCL2—pancreatitis	6.83e-05	0.000189	CbGpPWpGaD
Phenylpropanolamine—MAOA—Metabolism—ALB—pancreatitis	6.73e-05	0.000187	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—HTR2A—pancreatitis	6.72e-05	0.000186	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Hemostasis—KRAS—pancreatitis	6.5e-05	0.00018	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—PDGFA—pancreatitis	6.44e-05	0.000179	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—NRAS—pancreatitis	6.41e-05	0.000178	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—CXCL8—pancreatitis	6.4e-05	0.000177	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—LEP—pancreatitis	6.39e-05	0.000177	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—ALDH2—pancreatitis	6.36e-05	0.000176	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—CCL5—pancreatitis	6.31e-05	0.000175	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—LEP—pancreatitis	6.25e-05	0.000173	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatitis	6.2e-05	0.000172	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—LPL—pancreatitis	6.17e-05	0.000171	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—INS—pancreatitis	6.07e-05	0.000168	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—CCL2—pancreatitis	5.97e-05	0.000166	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—CXCL8—pancreatitis	5.95e-05	0.000165	CbGpPWpGaD
Phenylpropanolamine—MAOA—Metabolism—PTGS2—pancreatitis	5.89e-05	0.000163	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—CCL5—pancreatitis	5.86e-05	0.000162	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—SPP1—pancreatitis	5.84e-05	0.000162	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—CXCL8—pancreatitis	5.81e-05	0.000161	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—NRAS—pancreatitis	5.77e-05	0.00016	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—LPL—pancreatitis	5.73e-05	0.000159	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—NRAS—pancreatitis	5.64e-05	0.000156	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—pancreatitis	5.58e-05	0.000155	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—HTR2A—pancreatitis	5.56e-05	0.000154	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Hemostasis—HRAS—pancreatitis	5.53e-05	0.000153	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—KRAS—pancreatitis	5.52e-05	0.000153	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—INS—pancreatitis	5.46e-05	0.000151	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—SPP1—pancreatitis	5.43e-05	0.00015	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—CXCL8—pancreatitis	5.4e-05	0.00015	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—CCL2—pancreatitis	5.37e-05	0.000149	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—INS—pancreatitis	5.34e-05	0.000148	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—CCL2—pancreatitis	5.25e-05	0.000146	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—LEP—pancreatitis	5.17e-05	0.000143	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—HTR2A—pancreatitis	5.17e-05	0.000143	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—MDM2—pancreatitis	5.05e-05	0.00014	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—PPARG—pancreatitis	5e-05	0.000139	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—KRAS—pancreatitis	4.96e-05	0.000138	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—INS—pancreatitis	4.91e-05	0.000136	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatitis	4.88e-05	0.000135	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—KRAS—pancreatitis	4.85e-05	0.000135	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—GCG—pancreatitis	4.82e-05	0.000134	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—LEP—pancreatitis	4.8e-05	0.000133	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—CXCL8—pancreatitis	4.72e-05	0.000131	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—HRAS—pancreatitis	4.69e-05	0.00013	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—NRAS—pancreatitis	4.66e-05	0.000129	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—MDM2—pancreatitis	4.54e-05	0.000126	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—CASP3—pancreatitis	4.52e-05	0.000125	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—ALB—pancreatitis	4.5e-05	0.000125	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—IL6—pancreatitis	4.49e-05	0.000124	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—MDM2—pancreatitis	4.44e-05	0.000123	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—INS—pancreatitis	4.42e-05	0.000122	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—CCL2—pancreatitis	4.34e-05	0.00012	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—NRAS—pancreatitis	4.33e-05	0.00012	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—CXCL8—pancreatitis	4.25e-05	0.000118	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—HRAS—pancreatitis	4.22e-05	0.000117	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—CXCL8—pancreatitis	4.15e-05	0.000115	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—HRAS—pancreatitis	4.13e-05	0.000114	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—INS—pancreatitis	4.1e-05	0.000114	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—CASP3—pancreatitis	4.06e-05	0.000113	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—IL6—pancreatitis	4.04e-05	0.000112	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—CCL2—pancreatitis	4.04e-05	0.000112	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—KRAS—pancreatitis	4.01e-05	0.000111	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—CASP3—pancreatitis	3.97e-05	0.00011	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—IL6—pancreatitis	3.95e-05	0.000109	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—PTGS2—pancreatitis	3.94e-05	0.000109	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—NRAS—pancreatitis	3.79e-05	0.000105	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—LPL—pancreatitis	3.78e-05	0.000105	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—KRAS—pancreatitis	3.73e-05	0.000103	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—MDM2—pancreatitis	3.67e-05	0.000102	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—TGFB1—pancreatitis	3.52e-05	9.76e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—CXCL8—pancreatitis	3.43e-05	9.52e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—MDM2—pancreatitis	3.41e-05	9.46e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—HRAS—pancreatitis	3.41e-05	9.46e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—NRAS—pancreatitis	3.41e-05	9.44e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—NRAS—pancreatitis	3.33e-05	9.23e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—CASP3—pancreatitis	3.29e-05	9.11e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—IL6—pancreatitis	3.27e-05	9.05e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—KRAS—pancreatitis	3.26e-05	9.04e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—CXCL8—pancreatitis	3.19e-05	8.85e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—HRAS—pancreatitis	3.17e-05	8.79e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—TGFB1—pancreatitis	3.16e-05	8.77e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—TGFB1—pancreatitis	3.1e-05	8.58e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—CASP3—pancreatitis	3.05e-05	8.47e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—IL6—pancreatitis	3.03e-05	8.41e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—KRAS—pancreatitis	2.93e-05	8.12e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—KRAS—pancreatitis	2.87e-05	7.95e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—HRAS—pancreatitis	2.77e-05	7.68e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—PPARG—pancreatitis	2.76e-05	7.65e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—NRAS—pancreatitis	2.76e-05	7.64e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—INS—pancreatitis	2.71e-05	7.51e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—IL6—pancreatitis	2.65e-05	7.35e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—TGFB1—pancreatitis	2.56e-05	7.1e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—NRAS—pancreatitis	2.56e-05	7.1e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—HRAS—pancreatitis	2.49e-05	6.91e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—ALB—pancreatitis	2.48e-05	6.88e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—HRAS—pancreatitis	2.44e-05	6.76e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—IL6—pancreatitis	2.38e-05	6.61e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—TGFB1—pancreatitis	2.38e-05	6.59e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—KRAS—pancreatitis	2.37e-05	6.57e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—IL6—pancreatitis	2.33e-05	6.47e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—KRAS—pancreatitis	2.2e-05	6.11e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—PTGS2—pancreatitis	2.17e-05	6.02e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—HRAS—pancreatitis	2.02e-05	5.59e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—IL6—pancreatitis	1.93e-05	5.35e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—HRAS—pancreatitis	1.87e-05	5.19e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—IL6—pancreatitis	1.79e-05	4.97e-05	CbGpPWpGaD
